Acute Kidney Injury Secondary to Pegylated Liposomal Doxorubicin-Associated Renal-limited Thrombotic Microangiopathy

The emergence of pegylated liposomal doxorubicin (PLD) as a preferred treatment for various malignancies, because of its reduced cardiotoxicity compared with conventional doxorubicin, has raised significant interest. However, the association between PLD and thrombotic microangiopathy (TMA) remains a...

Full description

Bibliographic Details

Published in:	Kidney Medicine
Main Authors:	Tarek S. Karam, Mrinalini Sarkar, Jonathan E. Zuckerman
Format:	Article
Language:	English
Published:	Elsevier 2025-05-01
Subjects:	Doxil kidney biopsy onconephrology pegylated liposomal doxorubicin thrombotic microangiopathy (TMA) renal pathology
Online Access:	http://www.sciencedirect.com/science/article/pii/S2590059525000342